FILE PHOTO: A sign is pictured during the unveiling of AstraZeneca’s new manufacturing facility, to be operational in the coming months with an initial focus on T-cell therapies, in Rockville, Maryland, U.S., May 5, 2025. REUTERS/Jonathan Ernst/File Photo